Other Name
Sponsors Type
Federal/National
Country
United States
Grant Types
Fellowship/Scholarship/Dissertation Research Project Training/Course Workshop/Conference Post-doctoral Collaboration/Cooperative Agreement Equipment/Facility/Organization Publishing/Editorial
 Contact Info
Phone
301-495-4484
Fax
301-718-6366
Email
NIAMSinfo@mail.nih.gov
Address
1 AMS Circle, Bethesda, MD 20892-3675
Last modified on 2025-02-09 22:10:39
Description
MISSION The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases.
Sponsor Relationship

  National Institute of Arthritis and Musculoskeletal and Skin Diseases is a part of:


  No sponsor in our database are part of National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Most Recent Grants from This Sponsors
Funding Opportunity Number: RFA-AT-25-003 **Purpose** The purpose of this HEAL Initiative...
Added on 2025-01-08T18:17:08Z
Funding Opportunity Number: PAR-25-355 **Background** Currently, roughly 53%of American...
Added on 2025-01-08T18:09:45Z
Funding Opportunity Number: PAR-25-354 **Background** Currently, roughly 53%of American...
Added on 2025-01-08T18:09:17Z
Funding Opportunity Number: PA-25-305 The NIH Research Project Grant supports a discrete,...
Added on 2024-12-18T18:22:33Z
Deadline Approaching Grants
Funding Opportunity Number: RFA-NS-23-007 **Purpose** The purpose of this Funding Opportunity...
Deadline on 2025-04-04T00:00:00Z
Funding Opportunity Number: RFA-NS-23-006 **Purpose** The purpose of this Funding Opportunity...
Deadline on 2025-04-04T00:00:00Z
Funding Opportunity Number: PAR-23-032 Section I. Funding Opportunity...
Deadline on 2025-04-05T00:00:00Z
Funding Opportunity Number: PAR-23-219 The NIH Small Business Innovation Research (SBIR) and...
Deadline on 2025-04-05T00:00:00Z